Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery (Q37691664)

22 August 2017

1 reference

title

Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery (English)

1 reference

22 August 2017

0 references

0 references

G Mingrone

1

1 reference

PubMed ID

20152737

22 August 2017

L Castagneto-Gissey

series ordinal

2

1 reference

22 August 2017

1 December 2009

1 reference

22 August 2017

Diabetes and Metabolism

1 reference

22 August 2017

35

1 reference

22 August 2017

518-523

1 reference

22 August 2017

6 Pt 2

1 reference

Gastrointestinal Surgery for Severe Obesity

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Surgical treatment of obesity and its effect on diabetes: 10-y follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Laparoscopic Roux-en-Y gastric bypass for BMI < 35 kg/m(2): a tailored approach.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI < 35 kg/m2

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

The effect of bilio-pancreatic diversion on type 2 diabetes in patients with BMI <35 kg/m2.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Ontogeny of the endocrine pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Intestinal Nutrient Influence on the Enteroinsular Axis*

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Developmental aspects of gastric inhibitory polypeptide (GIP) and its possible role in the enteroinsular axis in neonates.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Incretin effect potentiates beta-cell responsivity to glucose as well as to its rate of change: OGTT and matched intravenous study.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Mechanism for improved insulin sensitivity after gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Laparoscopic adjustable gastric banding for patients with body mass index of <or=35 kg/m2.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

The Physiology of Glucagon-like Peptide 1

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Biological actions and therapeutic potential of the glucagon-like peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2809%2973459-7

7 January 2021

10.1016/S1262-3636(09)73459-7

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20152737